Christopher Cabell

Christopher Cabell

Net worth: 1 M $ as of 31/10/2026

57 year
Health Technology
Consumer Services
Commercial Services

Profile

Christopher H.
Cabell
is Chief Executive Officer at CorHepta Pharmaceuticals, Inc. since 2024.
Director at ScienceMedia, Inc. since 2020.
Independent Director at Pulmatrix, Inc. since 2020.
Member at American College of Cardiology Foundation.
President & Head-Research & Development at Inhibikase Therapeutics, Inc. starting 2025.
Formerly Chief Medical Officer & Executive Vice President at Zura Bio Ltd. from 2023 to 2024.
Chief Medical Officer & Head-Clinical Development at Emergent BioSolutions, Inc. from 2021 to 2023.
Chief Medical Officer, Head-Research & Development at Arena Pharmaceuticals, Inc. in 2020.
Senior VP & Head-Therapeutic Delivery Unit at Quintiles Transnational Corp.
from 2015 to 2017.
Chief Medical & Scientific Officer at Quintiles, Inc. (California), IQVIA RDS, Inc., and IQVIA, Inc. from 2007 to 2017.
Director at Cenduit LLC.
Director-Echocardiography Core Lab at Duke Clinical Research Institute.
Co-Chairman at US Food & Drug Administration and Cardiac Safety Research Consortium.
Associate Professor at Duke University School of Medicine.
Education includes graduate degree from Duke University, undergraduate degree from The Pennsylvania State University, and doctorate from Duke University School of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
15/04/2026 6,76,564 ( 0.48% ) 1 M $ 31/10/2026
28/08/2026 0 ( -.--% ) - $ 31/10/2026

Christopher Cabell active positions

CompaniesPositionStart
INHIBIKASE THERAPEUTICS, INC. President 21/02/2025
PULMATRIX, INC. Director/Board Member 23/06/2020
Director/Board Member 18/02/2020
Corporate Officer/Principal 30/04/2009

Former positions of Christopher Cabell

CompaniesPositionEnd
ZURA BIO LIMITED Chief Tech/Sci/R&D Officer 15/01/2024
EMERGENT BIOSOLUTIONS INC. Chief Tech/Sci/R&D Officer 01/01/2023
ARENA PHARMACEUTICALS Chief Tech/Sci/R&D Officer 01/12/2020
Chief Tech/Sci/R&D Officer 01/09/2017
Chief Tech/Sci/R&D Officer 22/07/2011
See the detail of Christopher Cabell's experience

Education of Christopher Cabell

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

68

1st degree connections

18

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies18

Commercial Services

Technology Services

Health Technology

Health Services

Consumer Services

Health Technology

Consumer Services

Health Technology

Government

Health Services

Commercial Services

Technology Services

Distribution Services

Health Technology

Consumer Services

Health Technology

Cardiac Safety Research Consortium

Health Technology

  1. Stock Market
  2. Insiders
  3. Christopher Cabell